Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Dec 29, 2020 5:46pm
211 Views
Post# 32193904

RE:Anti-tumour Immunity Documented in PDT of Melanoma!

RE:Anti-tumour Immunity Documented in PDT of Melanoma!

Awesome find once again and it further confirms the Anti-Tumor Immune stimulation of PDT.  This should provide for a much longer CR status for our patients treated  in NMIBC trial and all others to come.  The vaccine like effect of PDT caused by the full Tumor destruction from PDT by ICD allows for an unprecedented potent vaccine effect IMO.because of the high dose of released DAMPs and associated Tumor antigens. Not just from partial Tumor destruction as in other treatment modalities, but by having pretty much full Tumor destruction after first treatment session.  All IMO  let's go 2021


"Ru PSs are extremely modular and thus highly tunable for a broad range of applications. Further, the incorporation of the heavy Ru atom leads to near-unity efficiency for the formation of triplet states, which are the states responsible for sensitizing singlet oxygen, from their initially excited singlet states. Specifically, in this study, we have (i) identified the optimal combination of ligands on Ru to achieve NIR-absorbing singlet states and lowest energy triplet states for singlet oxygen production, and (ii) demonstrated a potent cytotoxic effect on melanoma cells with NIR PDT. 2"

<< Previous
Bullboard Posts
Next >>